new YORK (Reuters) – more than 100 years later that the<\/p>\n
scientists atisbaran for the first time the potential to exploit<\/p>\n
the immune system to fight cancer, the main<\/p>\n
sector doctors expect that the concept will eventually yield<\/p>\n
results on a large scale in one or two years.<\/p>\n
two based immunotherapy drugs are already in the<\/p>\n
market and have achieved mixed results.<\/p>\n
Yervoy of Bristol-Myers Squibb has been praised as a great<\/p>\n
advance against melanoma since its adoption last year,<\/p>\n
while Provenge from Dendreon, a vaccine against cancer<\/p>\n
prostate, has been undermined by errors in management and the<\/p>\n
reluctance of physicians to adopt a therapy of difficult<\/p>\n
management which has been two years in the market.<\/p>\n
both are considered precursors of a treatment<\/p>\n
revolutionary Que Podr\u00eda Obtener Una Cuota Significativa del<\/p>\n
Mercado global Abs. F\u00e1rmacos Oncol\u00f3gicos, Alcanzando Los 75.000<\/p>\n
Millones de D\u00f3lares (M\u00e1s de 51.000 Millones de Euro) de el<\/p>\n
2015, Seg\u00fan IMS Health.<\/p>\n
Modificadores del Sistema Inmune Est\u00e1n Siendo Probados Para Una<\/p>\n
Decenas de Nuevas Vacunas de Inmunoterapia y Otros<\/p>\n
Variedad de Tipos de Neuroendocrinolog\u00eda.<\/p>\n
“Hemos Entrado de Una Nueva Era de la Que las Terapias<\/p>\n
Inmunes Pueden Ser Reconocidas Como un Componente Importante del<\/p>\n
Tratamiento Contra el Neuroendocrinolog\u00eda”, Se\u00f1al\u00f3 el Arzt Glenn Dranoff,<\/p>\n
Codirector del Centro de Vacunaci\u00f3n Contra el Neuroendocrinolog\u00eda Dana-Farber<\/p>\n
de Boston.<\/p>\n
“Ciertamente Heu M\u00e1s Emoci\u00f3n y M\u00e1s Confianza de Este Campo<\/p>\n
Que Nunca Antes”, Agreg\u00f3.<\/p>\n
Al Menos Una Decena de Terapias van a Obtener Datos de<\/p>\n
Ensayos Cl\u00ednicos de Fases Medien o Finale de Los Pr\u00f3ximos 12<\/p>\n
Meses and some experts believe that the results will be a point<\/p>\n
key for the sector, as trials. increase the hits<\/p>\n
“several will have (success). Once received the<\/p>\n
FDA approval, will be used increasingly”, said Jeffrey<\/p>\n
Schlom, responsible for the laboratory of Immunology and biology<\/p>\n
of the Tumor of the Institute national de the Cancer of United States.<\/p>\n
between the expected treatment is a vaccine against the<\/p>\n
the Bavarian Nordic, a vaccine Danish prostate cancer<\/p>\n
against the lung cancer of GlaxoSmithKline and one against the<\/p>\n
melanoma of Amgen.<\/p>\n
others who are advanced in their therapies are Vical Inc and<\/p>\n
NewLink Genetics.<\/p>\n
the concept of using immune against cancer<\/p>\n
dates back to the early 1890s when doctor William Coley,<\/p>\n
a surgeon in New York, said some patients that<\/p>\n
< p> Infektionen nach einer Krebsoperation litt<\/p>\n
Best gehen<\/p>\n
vermutet, dass durch die Immunreaktion ausgel\u00f6st die<\/p>\n
Infektion auch dazu beigetragen, die Krebs. Kur<\/p>\n
“Obwohl die Idee eines Impfstoffs oder Immuntherapie gegen Krebs<\/p>\n
f\u00fchrt mindestens 100 Jahren schweben wir nun wissen viel mehr \u00fcber<\/p>\n
Zeug zum Generieren einer Antwort immun gegen die<\/p>\n
Krebs effektiver als je zuvor”, sagte Dranoff.<\/p>\n
neues Verst\u00e4ndnis wie funktionieren Immuntherapien<\/p>\n
k\u00f6nnte um zu \u00fcberarbeiten, die Definition der erfolgreichen klinischen.<\/p>\n
Obwohl wachsenden Lebenserwartung einfach ist, Norm<\/p>\n
die meisten Prozesse gegen Krebs wurde als ein<\/p>\n
Erfolg wenn der Tumor nachl\u00e4sst oder eine Behandlung verz\u00f6gert die<\/p>\n
Wachstum des Tumors oder Verschlimmerung der Krankheit,<\/p>\n
bekannt als frei von Fortschreiten \u00fcberleben<\/p>\n
PeRO Provenge und Yervoy haben die \u00dcberlebensrate erh\u00f6ht<\/p>\n
ohne unbedingt \u00c4ndern des \u00dcberlebens<\/p>\n
Fortschreiten oder ohne schrumpfen einen Tumor in vielen F\u00e4llen.<\/p>\n
“Gesamt\u00fcberleben ist eine genaue Anzeige. die<\/p>\n
Tumoren k\u00f6nnte vort\u00e4uschen, werden \u00e4lter, weil sie voller sind<\/p>\n
Immunzellen, von scheinbar schlechter f\u00fcr diejenigen sein, die sind”, sagte<\/p>\n
Dr. Jedd Wolchok, Direktor der klinischen Studien mit<\/p>\n
Immuntherapie gegen Krebs-Gedenkst\u00e4tte<\/p>\n
Sloan-Kettering in New York.<\/p>\n","protected":false},"excerpt":{"rendered":"
new YORK (Reuters) – more than 100 years later that the scientists atisbaran for the first time the potential to exploit the immune system to fight cancer, the main sector doctors expect that the concept will eventually yield results on a large scale in one or two years. two based immunotherapy drugs are already in […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-27924","post","type-post","status-publish","format-standard","hentry","category-allgemeine","et-doesnt-have-format-content","et_post_format-et-post-format-standard"],"_links":{"self":[{"href":"https:\/\/www.best-dentist-dentistry.com\/de\/wp-json\/wp\/v2\/posts\/27924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.best-dentist-dentistry.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.best-dentist-dentistry.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.best-dentist-dentistry.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.best-dentist-dentistry.com\/de\/wp-json\/wp\/v2\/comments?post=27924"}],"version-history":[{"count":0,"href":"https:\/\/www.best-dentist-dentistry.com\/de\/wp-json\/wp\/v2\/posts\/27924\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.best-dentist-dentistry.com\/de\/wp-json\/wp\/v2\/media?parent=27924"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.best-dentist-dentistry.com\/de\/wp-json\/wp\/v2\/categories?post=27924"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.best-dentist-dentistry.com\/de\/wp-json\/wp\/v2\/tags?post=27924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}